Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Monday, June 6, 2011

Health-care video company SBR attracts $1.67M funding

By James M. Connolly

Cambridge startup SBR Health has brought in a $1.67 million equity investment involving entrepreneur Mike Maples Jr.’s Floodgate Fund LP, according to a document filed with the U.S. Securities and Exchange Commission.

SBR Health was founded in 2010 by CEO Chris Herot, a veteran of Lotus Development Corp. and former chief product officer at video company VSee Lab. SBR Health is developing real-time video communications software designed to help health-care professionals communicate with specialists and patients to improve delivery of treatments.

Herot’s co-founder is chairman James Gibbons, who is a professor of electrical engineering at Stanford University. He has been an advisor and board member of various companies, including Cisco Systems Inc. and VSee Lab. 

The SEC document listed Maples as an involved party. Maples is the managing partner of Floodgate, and co-founded Motive Inc., a broadband software company in 1997.


 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

Should RI officials have approved the $75M loan to 38 Studios?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.